Do we need anti-obesity drugs?

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F12%3A43907102" target="_blank" >RIV/00216208:11120/12:43907102 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00023761:_____/12:#0000221

Výsledek na webu

<a href="http://dx.doi.org/10.1002/dmrr.2349" target="_blank" >http://dx.doi.org/10.1002/dmrr.2349</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/dmrr.2349" target="_blank" >10.1002/dmrr.2349</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Do we need anti-obesity drugs?

Popis výsledku v původním jazyce

The increasing global prevalence of obesity urgently requires an implementation of efficient preventive and therapeutic measures. Weight loss and its maintenance should be considered one of the most important strategies to reduce the incidence of obesity-related co-morbidities such as diabetes and cardiovascular diseases. Lifestyle modification focused on diet and physical activity represents the essential component of any kind of weight management. However, only an intensive lifestyle intervention canbe efficient in terms of long-term weight loss. Anti-obesity drugs affect different targets in the central nervous system or peripheral tissues and improve regulatory and metabolic disturbances that contribute to the development of obesity. Anti-obesitymedications provide modest additional fat loss to that achieved by lifestyle modification alone, reduce visceral fat stores, improve programme adherence, weight loss maintenance, diminish obesity-related health risks and improve a quality

Název v anglickém jazyce

Do we need anti-obesity drugs?

Popis výsledku anglicky

The increasing global prevalence of obesity urgently requires an implementation of efficient preventive and therapeutic measures. Weight loss and its maintenance should be considered one of the most important strategies to reduce the incidence of obesity-related co-morbidities such as diabetes and cardiovascular diseases. Lifestyle modification focused on diet and physical activity represents the essential component of any kind of weight management. However, only an intensive lifestyle intervention canbe efficient in terms of long-term weight loss. Anti-obesity drugs affect different targets in the central nervous system or peripheral tissues and improve regulatory and metabolic disturbances that contribute to the development of obesity. Anti-obesitymedications provide modest additional fat loss to that achieved by lifestyle modification alone, reduce visceral fat stores, improve programme adherence, weight loss maintenance, diminish obesity-related health risks and improve a quality

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FB - Endokrinologie, diabetologie, metabolismus, výživa

OECD FORD obor

—

Projekt

—

Návaznosti

Z - Vyzkumny zamer (s odkazem do CEZ)

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Diabetes - Metabolism Research and Reviews

ISSN

1520-7552

e-ISSN

—

Svazek periodika

28

Číslo periodika v rámci svazku

Suppl. 2

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

13

Strana od-do

8-20

Kód UT WoS článku

000312944300002

EID výsledku v databázi Scopus

—